Increase in endogenous cortisol production achieved in all patients in higher dose cohorts of BBP-631, a result seen for the first time ever in ...

In a report released on September 6, Mohit Bansal from Wells Fargo maintained a Buy rating on Mineralys Therapeutics, Inc. (MLYS – ...

High blood pressure, or hypertension, is a serious health issue that can lead to heart disease, strokes, and other problems.

Heart failure arises when the heart cannot pump blood efficiently, leading to symptoms such as shortness of breath and ...

Few things are worse than waking up drenched in the middle of the night, one leg hooked outside of the duvet, sweating as if ...

Mineralys has been on the radar for some biotech investors. Read more about MLYS' hypertension treatment, upcoming trial ...

A viral “cortisol cocktail” for weight loss is taking social media by storm. Not that kind of cocktail, but rather a mix of ...

Obesity is a key factor in cardiovascular disease, prompting the ESC to recommend comprehensive strategies for prevention and ...

Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD, discuss the use of beta-blocker therapy following acute MI ...

Trial follow-up data showed no improvement in kidney failure and death risks among blood pressure-lowering strategies for patients with ADPKD.

The DIAMOND study as it relates to patiromer was initially built on the hypothesis that we could improve adherence and maintenance of optimal guideline-based medical therapies, specifically the ...